4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-22-034577
Chief Financial Officer acquired 42,500 shares (grant or award)
- Chief Financial Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Arkowitz David · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-15 | Exercise or conversion : show line 1 in the form | +5,000 | 70,492 | D |
| 2022-10-27 | Grant or award : show line 2 in the form | +42,500 | 112,992 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-15 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −5,000 | 0 | D |
Loading xslF345X03/doc4.xml…